Mirum Pharmaceuticals, Inc. (MIRM) /
The cash flow of Mirum Pharmaceuticals, Inc. over the past 7 years
Chart Mirum Pharmaceuticals, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2019–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Mirum Pharmaceuticals, Inc.'s operating cash flow was $55.83M and its capital expenditures $954K, leaving free cash flow of $54.87M. Free cash flow was above zero in 2 of the 7 years shown. It ranged from -$132.78M in fiscal 2021 to $54.87M in fiscal 2025. Capital expenditures were highest in fiscal 2024, at $993K.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $55.83M | $954K | $54.87M |
| 2024ended Dec 31, 2024 | $10.32M | $993K | $9.33M |
| 2023ended Dec 31, 2023 | -$70.94M | $109K | -$71.05M |
| 2022ended Dec 31, 2022 | -$120.14M | $278K | -$120.41M |
| 2021ended Dec 31, 2021 | -$132.76M | $24K | -$132.78M |
| 2020ended Dec 31, 2020 | -$89.08M | $225K | -$89.3M |
| 2019ended Dec 31, 2019 | -$39.36M | $281K | -$39.64M |
Fiscal years as Mirum Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Mirum Pharmaceuticals, Inc.
- The revenue of Mirum Pharmaceuticals, Inc.
- The profitability of Mirum Pharmaceuticals, Inc.
- The debt of Mirum Pharmaceuticals, Inc.
- All of Mirum Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- CNOCNO Financial Group, Inc.
- AROCArchrock, Inc.
- BRZEBraze, Inc.
- TENBTENABLE HOLDINGS, INC.
- UNFUNIFIRST CORPORATION
Not investment advice. This page shows what Mirum Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.